HURA

1.2508.09%
JA

James A. Bianco

President, CEO & Director

Dr. James A. Bianco, also known as Jim, M.D., serves as Chief Executive Officer and President of Tuhura Biosciences, Inc (formerly known as Morphogenesis, Inc). and serves as its Director since July 01, 2021. He served as Chief Development Officer at Prothex, Inc. He served as the Chief Executive Officer of Cell Therapeutics Europe S.R.L., a subsidiary of CTI BioPharma Corp. Dr. Bianco was the Principal Founder of CTI BioPharma Corp. and served as its Chief Executive Officer since February 1992 until October 2, 2016 and also served as its President since July 25, 2012 until October 2, 2016. He also served as the President of CTI BioPharma Corp. from February 1992 to 2008 and also served as its Chief Employee Officer. He served as an Assistant Professor of Medicine at the University of Washington, Seattle. He served as an Assistant Member in the Clinical Research Division of the Fred Hutchinson Cancer Research Center. He served as an Executive Director of CTI BioPharma Corp. since September 1991 until October 2, 2016 and served as its Member of Scientific Advisory Board. From 1990 to 1992, he served as the Director of the Bone Marrow Transplant Program at the Veterans Administration Medical Center in Seattle. Dr. Bianco holds his B.S. degree in Biology and Physics from New York University and his M.D. from Mount Sinai School of Medicine.

Positions